Clinical Trials Directory

Trials / Completed

CompletedNCT03777371

Anti-HIV False Positivity Rate in Pregnant Women; and Investigating the Factors Affecting This Situation

Status
Completed
Phase
Study type
Observational
Enrollment
128 (actual)
Sponsor
Kanuni Sultan Suleyman Training and Research Hospital · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

HIV virus is an etiologic agent of ( AIDS ) immunodeficiency syndrome . It is known that the estimated rate of transfer from mother to baby is 25% to 45%, pregnancy rate is 5-10%, pregnancy rate is 15-20% and in lactation period is 5-10%. Risk factors; maternal viral load, breastfeeding, vaginal birth, and prematurity. Although there is a high rate of false positivity in prenatal screening in our country, one of the factors affecting this is the number of pregnancies.

Conditions

Interventions

TypeNameDescription
OTHERAnti HIV Seropositive Pregnant Women

Timeline

Start date
2014-01-01
Primary completion
2018-12-01
Completion
2018-12-01
First posted
2018-12-17
Last updated
2018-12-17

Source: ClinicalTrials.gov record NCT03777371. Inclusion in this directory is not an endorsement.